|
MPHOSPH6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.244400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.969600E-01 |
| Normal-vs-Stage2 |
5.984000E-01 |
| Normal-vs-Stage3 |
6.770800E-01 |
| Normal-vs-Stage4 |
7.161000E-01 |
| Stage1-vs-Stage2 |
8.628400E-01 |
| Stage1-vs-Stage3 |
1.385250E-01 |
| Stage1-vs-Stage4 |
6.034400E-01 |
| Stage2-vs-Stage3 |
4.096800E-01 |
| Stage2-vs-Stage4 |
8.361000E-01 |
| Stage3-vs-Stage4 |
4.359600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.361400E-01 |
| Normal-vs-AfricanAmerican |
5.938600E-01 |
| Normal-vs-Asian |
6.615200E-01 |
| Caucasian-vs-AfricanAmerican |
8.314400E-01 |
| Caucasian-vs-Asian |
5.627200E-01 |
| AfricanAmerican-vs-Asian |
5.032600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.918400E-01 |
| Normal-vs-Female |
5.417800E-01 |
| Male-vs-Female |
8.118000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.133000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.543600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.468400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.719600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.618600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.666400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.889800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.908400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.995200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.190400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.246600E-01 |
| Normal-vs-Grade 2 |
4.544600E-01 |
| Normal-vs-Grade 3 |
9.592800E-01 |
| Normal-vs-Grade 4 |
8.392400E-01 |
| Grade 1-vs-Grade 2 |
8.781200E-01 |
| Grade 1-vs-Grade 3 |
5.858800E-01 |
| Grade 1-vs-Grade 4 |
6.348000E-01 |
| Grade 2-vs-Grade 3 |
3.191200E-01 |
| Grade 2-vs-Grade 4 |
6.539600E-01 |
| Grade 3-vs-Grade 4 |
8.375600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.227800E-01 |
| Normal-vs-ccB subtype |
6.392400E-01 |
| ccA subtype-vs-ccB subtype |
9.236400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.370400E-01 |
| Normal-vs-N1 |
8.581800E-01 |
| N0-vs-N1 |
6.854400E-01 |
|
|
